POLR3B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.913800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.658600E-01
Normal-vs-Stage2
4.707200E-01
Normal-vs-Stage3
8.123600E-02
Normal-vs-Stage4
7.851800E-01
Stage1-vs-Stage2
2.135600E-02
Stage1-vs-Stage3
2.492100E-02
Stage1-vs-Stage4
2.895000E-01
Stage2-vs-Stage3
2.140800E-01
Stage2-vs-Stage4
6.451400E-01
Stage3-vs-Stage4
1.346400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.050400E-01
Normal-vs-AfricanAmerican
8.094200E-01
Normal-vs-Asian
1.612150E-01
Caucasian-vs-AfricanAmerican
2.141400E-01
Caucasian-vs-Asian
1.232830E-01
AfricanAmerican-vs-Asian
8.133800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.785400E-01
Normal-vs-Female
4.875800E-01
Male-vs-Female
4.866200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.158600E-01
Normal-vs-Age(41-60Yrs)
6.425000E-01
Normal-vs-Age(61-80Yrs)
5.308800E-01
Normal-vs-Age(81-100Yrs)
9.677200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.866200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.135400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.077000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.138200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.600000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.020600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.345400E-01
Normal-vs-Daily Drinker
2.522000E-01
Normal-vs-Weekly Drinker
4.057800E-01
Normal-vs-Occasional Drinker
8.880000E-01
Normal-vs-Social Drinker
7.758400E-01
Non Drinker-vs-Daily Drinker
4.081400E-01
Non Drinker-vs-Weekly Drinker
7.779200E-01
Non Drinker-vs-Occasional Drinker
2.579400E-01
Non Drinker-vs-Social Drinker
5.314000E-01
Daily Drinker-vs-Weekly Drinker
6.907800E-01
Daily Drinker-vs-Occasional Drinker
8.867900E-02
Daily Drinker-vs-Social Drinker
2.435600E-01
Weekly Drinker-vs-Occasional Drinker
2.639000E-01
Weekly Drinker-vs-Social Drinker
4.909600E-01
Occasional Drinker-vs-Social Drinker
7.567800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.044800E-01
Normal-vs-Grade 2
4.793600E-01
Normal-vs-Grade 3
3.831400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.871580E-01
Grade 1-vs-Grade 3
5.667800E-01
Grade 1-vs-Grade 4
4.044800E-01
Grade 2-vs-Grade 3
2.725800E-01
Grade 2-vs-Grade 4
4.793600E-01
Grade 3-vs-Grade 4
3.831400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.383800E-01
Normal-vs-NonDiabetic
4.921200E-01
Diabetic-vs-NonDiabetic
8.112800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.258200E-02
Normal-vs-NoPancreatitis
5.672600E-01
Pancreatitis-vs-NoPancreatitis
6.315200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.632800E-01
Normal-vs-N1
4.825800E-01
N0-vs-N1
4.797200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.308200E-01
Normal-vs-TP53-NonMutant
6.825200E-01
TP53-Mutant-vs-TP53-NonMutant
1.058280E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
